CoChat

Retracted: ‘Clinical trials in Alzheimer’s disease’: immunotherapy approaches

Open access
Delrieu, Julien, Ousset, Pierre Jean, Caillaud, Céline, Vellas, Bruno · 2012 · Journal of Neurochemistry
Cited by 139

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Abstract

J. Neurochem. (2012) 120 (Suppl. 1), 186–193. Recent advances in the understanding of Alzheimer’s disease pathogenesis have led to the development of numerous compounds that might modify the disease process. Amyloid β (Aβ) peptide represents an important molecular target for intervention in Alzheimer’s disease. Several types of Aβ peptide immunotherapy for Alzheimer’s disease are under investigation, direct immunization with synthetic intact Aβ 42, active immunization involving the administration of synthetic fragments of Aβ peptide conjugated to a carrier protein and passive administration with monoclonal antibodies directed against Aβ peptide. Pre‐clinical studies showed that immunization against Aβ peptide can provide protection and reversal of the pathology of Alzheimer’s disease in animal models. Indeed, several adverse events have been described like meningoencephalitis with AN1792, vasogenic edema and microhemorrhages with bapineuzumab. Although immunotherapy approaches resulted in clearance of amyloid plaques in patients with Alzheimer’s disease, this clearance did not show significant cognitive effect for the moment. Currently, several Aβ peptide immunotherapy approaches are under investigation but also against tau pathology.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1471-4159.2011.07458.xThis paper is marked retracted.

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 15 references

Cited by

See all 139

Metadata

Authors
Delrieu, J., Ousset, P. J., Caillaud, C., & Vellas, B.
Venue
Journal of Neurochemistry
Publisher
Wiley
Published
2011-11-28
Volume
120
Issue
s1
Pages
186-193
ISSN
  • 0022-3042 (ISSN-L)
  • 1471-4159
OpenAlex
W1565463013
Cited by
139
References
15
FWCI
15.22
Type
journal article
Language
en
Status
Retracted
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Retracted: ‘Clinical trials in Alzheimer’s disease’: immunotherapy approaches. https://app.cochat.ai/papers/10.1111/j.1471-4159.2011.07458.x
The paper
Delrieu, J., Ousset, P. J., Caillaud, C., & Vellas, B. (2012). Retracted: ‘Clinical trials in Alzheimer’s disease’: immunotherapy approaches. Journal of Neurochemistry. https://doi.org/10.1111/j.1471-4159.2011.07458.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.